Kathryn B. Hyer
Direktor/Vorstandsmitglied bei Pier Pharmaceuticals, Inc.
Profil
Kathryn B.
Hyer is the founder of Everen Securities, Inc. She currently holds a Director position at Pier Pharmaceuticals, Inc. Ms. Hyer has previously held Director positions at RespireRx Pharmaceuticals, Inc., Zevex International, Inc., and Diagnostic Photonics, Inc. She was also the Chief Financial Officer at Quark Pharmaceuticals, Inc. Ms. Hyer's education includes an undergraduate degree from Aquinas College (Michigan).
Aktive Positionen von Kathryn B. Hyer
| Unternehmen | Position | Beginn |
|---|---|---|
Pier Pharmaceuticals, Inc.
 Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO. | Direktor/Vorstandsmitglied | 03.11.2009 |
Ehemalige bekannte Positionen von Kathryn B. Hyer
| Unternehmen | Position | Ende |
|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | - |
Zevex International, Inc.
 Zevex International, Inc. Electronic Equipment/InstrumentsElectronic Technology Zevex International, Inc. manufactures, designs and distributes medical devices. It distributes portable & stationary pumps and disposable sets that are used in the delivery of enteral nutrition for patients in homes, hospitals, and nursing homes. Its products include diagnostic & therapeutic systems, optoelectronic devices, ultrasonic sensors, and surgical handpieces. The company was founded in 1986 by David J. Mcnally and Phillip L. McStotts and is located in Salt Lake City, UT. | Corporate Officer/Principal | - |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Finanzdirektor/CFO | - |
| Everen Securities, Inc. | Gründer | - |
Diagnostic Photonics, Inc.
 Diagnostic Photonics, Inc. Medical SpecialtiesHealth Technology Diagnostic Photonics, Inc. develops imaging technology for intra-operative use in clinical settings. It product The Foresee Imaging System places a live view of tissue microstructure at the physician's fingertips, providing immediate insight into tissue microstructure. The company was founded by Stephen Boppart and P. Scott Carney in 2008 and is headquartered in Chicago, IL. | Vorstandsvorsitzender | - |
Ausbildung von Kathryn B. Hyer
| Aquinas College (Michigan) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Illinois Ventures LLC
 Illinois Ventures LLC Investment ManagersFinance Illinois Ventures LLC (Illinois Ventures) is a venture capital firm founded in 2000. The firm is headquartered in Champaign, Illinois. | Finance |
Pier Pharmaceuticals, Inc.
Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO. | Health Technology |
Diagnostic Photonics, Inc.
Diagnostic Photonics, Inc. Medical SpecialtiesHealth Technology Diagnostic Photonics, Inc. develops imaging technology for intra-operative use in clinical settings. It product The Foresee Imaging System places a live view of tissue microstructure at the physician's fingertips, providing immediate insight into tissue microstructure. The company was founded by Stephen Boppart and P. Scott Carney in 2008 and is headquartered in Chicago, IL. | Health Technology |
| Everen Securities, Inc. | Finance |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
Zevex International, Inc.
Zevex International, Inc. Electronic Equipment/InstrumentsElectronic Technology Zevex International, Inc. manufactures, designs and distributes medical devices. It distributes portable & stationary pumps and disposable sets that are used in the delivery of enteral nutrition for patients in homes, hospitals, and nursing homes. Its products include diagnostic & therapeutic systems, optoelectronic devices, ultrasonic sensors, and surgical handpieces. The company was founded in 1986 by David J. Mcnally and Phillip L. McStotts and is located in Salt Lake City, UT. | Electronic Technology |
